Helping engineering teams overcome integration, durability, and safety hurdles in harsh environments By Paulius Juskevicius, ...
Ticket sales for the third men’s T20I between India and New Zealand, to be played at the ACA Stadium on January 25, will go ...
Bristol-Myers Squibb's deucravacitinib – one of the main pipeline assets in its $74 billion takeover of Celgene in 2019 – has been approved in its first market as a treatment for moderate-to-severe ...
Bristol-Myers Squibb has formed an R&D partnership with GentiBio, aimed at developing regulatory T cel (Treg) therapies for inflammatory bowel disease (IBD). The deal includes an undisclosed upfront ...